Edition:
United Kingdom

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

78.00CHF
17 Jan 2018
Change (% chg)

CHF-0.45 (-0.57%)
Prev Close
CHF78.45
Open
CHF78.50
Day's High
CHF78.60
Day's Low
CHF77.30
Volume
35,096
Avg. Vol
56,603
52-wk High
CHF95.35
52-wk Low
CHF70.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 41.17 -1.899
FY 2016 Dec '16 35.31 -2.308
Jun '16 29.72 -2.759
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 2 91.25 98.10 84.40 109.85
Earnings (per share)
Year Ending Dec-18 1 -2.59 -2.59 -2.59 -1.50
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.57 32.89
P/E High - Last 5 Yrs. -- 278.73 45.60
P/E Low - Last 5 Yrs. -- 91.13 24.32
Beta 1.31 0.86 0.89
Price to Sales (TTM) 12.39 96.46 5.41
Price to Book (MRQ) -- 13.15 5.38
Price to Tangible Book (MRQ) -- 13.30 6.76
Price to Cash Flow (TTM) -- 72.66 23.42
% Owned Institutions -- 9.23 1.81

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.50
Dividend Yield - 5 Year Avg 1.21 0.27 1.51
Dividend 5 Year Growth Rate -- 1.77 5.22
Payout Ratio(TTM) -- 17.09 43.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 38.49 411.27 9.01
Sales (TTM) vs TTM 1 Yr. Ago 35.14 71.40 5.40
Sales - 5 Yr. Growth Rate -0.50 32.88 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.18 28.23 19.39
EPS (TTM) vs TTM 1 Yr. Ago 28.13 -- --
EPS - 5 Yr. Growth Rate -- 42.28 10.80
Capital Spending - 5 Yr. Growth Rate -34.31 40.23 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.78 1.75 2.18
Current Ratio (MRQ) 2.98 5.29 2.97
LT Debt to Equity (MRQ) -- 22.29 11.90
Total Debt to Equity (MRQ) -- 23.87 16.16
Interest Coverage (TTM) -17.38 -104.72 33.26

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.31 40.78 54.87
Gross Margin - 5 Yr. Avg. -- 52.54 52.46
EBITD Margin (TTM) -45.22 -- --
EBITD - 5 Yr. Avg -84.28 -245.78 15.31
Operating Margin (TTM) -48.03 -530.39 7.77
Operating Margin - 5 Yr. Avg. -89.66 -263.25 10.80
Pre-Tax Margin (TTM) -56.97 -505.16 8.57
Pre-Tax Margin - 5 Yr. Avg. -92.75 -263.07 11.21
Net Profit Margin (TTM) -57.44 -506.76 4.88
Net Profit Margin - 5 Yr. Avg. -93.21 -266.42 7.51
Effective Tax Rate (TTM) -- 23.32 23.08
Effective Tax Rate - 5 Yr. Avg. -- 18.85 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 318,667 24,014,979 859,855,848
Net Income/Employee (TTM) -183,042 3,190,719 101,151,536
Receivable Turnover (TTM) 27.34 20.63 5.76
Inventory Turnover (TTM) 0.45 2.12 3.33
Asset Turnover (TTM) 0.24 0.38 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.74 0.21 10.99
Return on Assets - 5 Yr. Avg. -14.90 0.98 12.42
Return on Investment (TTM) -17.70 3.42 14.44
Return on Investment - 5 Yr. Avg. -18.35 4.35 16.26
Return on Equity (TTM) -- 5.38 16.10
Return on Equity - 5 Yr. Avg. -78.01 8.97 17.54
  1 Year 3 Year 5 Year
Sales % 25.91 16.67 -0.50
EPS (TTM) % 16.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -4.81 99 50
13 Week -1.24 -5.17 99 61
26 Week -5.55 -11.79 99 69
52 Week 5.61 -6.73 99 46
YTD 9.37 -2.83 99 49
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 31.88%
# of Holders: 80
Total Shares Held: 3,784,727
3 Mo. Net Change: -245,559
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 13
# Reduced Positions: 9
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.